ALDA GUERRIER: Open Payments
NPI 1962985259 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 25 payments from 14 companies in 2025. Trend: 2023 $555 · 2024 $785 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Almatica Pharma LLC | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Validus Pharmaceuticals LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: LOREEV XR, REXULTI, COBENFY, CAPLYTA, VRAYLAR, SPRAVATO, HETLIOZ, Auvelity.
Industry payments across FL — which companies pay providers there.
